In humans, GLP-1 is not only damaged by DPP-4, but also by neutral endopeptidase 24.11 (NEP 24.11), and the main catalytic sites are Glu 27 Phe 28 and Trp 31 Leu 32
It signals your pituitary gland to release your own growth hormone, and growth hormone runs on a separate track from testosterone
3 The ClinicalTrials.gov Review Researchers analyzed all clinical trials registered on ClinicalTrials.gov related to GLP-1 drugs, and out of over 10,000 obesity-related trials, only 19 focused on the use of GLP-1 medications in children as of early 2023
Colleen P
Oral Tablets: Because GLP-1 pills have to be metabolized in the stomach, their bioavailability goes way down during digestion and exposure to stomach acids
99: 43364345, doi: Negro M, Perna S, Spadaccini D, Castelli L, Calanni L, Barbero M, Cescon C, Rondanelli M, DAntona G